Structure Therapeutics Inc. — Director's Dealing 2024

Aug 28, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2024-08-26

Reporting Person: Russell Angus C. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-26	Share option (right to buy)	$13.53	A	75000	Acquired	2034-08-25	Ordinary Shares (75000)	Direct

Footnotes

F1: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2: The shares vest in equal monthly installments over a three-year period such that the option is fully vested on the third anniversary of August 26, 2024.

F3: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.